Tevogen.AI Applauds U.S. Government's AI Action Plan; Reaffirms Commitment to Accelerating AI Innovation in Healthcare — Neutral
TVGN GlobeNewsWire — July 28, 2025WARREN, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today welcomes the White House's release of “Winning the Race: America's AI Action Plan”, issued July 23, 2025. The Company applauds the federal government's emphasis on establishing domain-specific standards, regulatory sandboxes (aka AI Centers of Excellence), and stakeholder convenings led by The National Institute of Standards and Technology to build trust, governance, and productivity in healthcare AI.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Simulations Plus, Inc. - SLP — Neutral
SLP GlobeNewsWire — July 28, 2025NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Simulations Plus, Inc. (“Simulations Plus” or the “Company”) (NASDAQ: SLP). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of United Natural Foods, Inc. - UNFI — Neutral
UNFI GlobeNewsWire — July 28, 2025NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of United Natural Foods, Inc. (“United Natural” or the “Company”) (NYSE: UNFI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Unlocking Alphabet (GOOGL) International Revenues: Trends, Surprises, and Prospects — Positive
GOOG GOOGL Zacks Investment Research — July 28, 2025Evaluate Alphabet's (GOOGL) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

IBM (IBM) Reliance on International Sales: What Investors Need to Know — Neutral
IBM Zacks Investment Research — July 28, 2025Examine IBM's (IBM) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

Unlocking Imax (IMAX) International Revenues: Trends, Surprises, and Prospects — Neutral
IMAX Zacks Investment Research — July 28, 2025Examine the evolution of Imax's (IMAX) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

Interpreting Jakks (JAKK) International Revenue Trends — Neutral
JAKK Zacks Investment Research — July 28, 2025Explore how Jakks' (JAKK) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

Don't Overlook Amphenol (APH) International Revenue Trends While Assessing the Stock — Neutral
APH Zacks Investment Research — July 28, 2025Explore how Amphenol's (APH) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

Don't Overlook Lear (LEA) International Revenue Trends While Assessing the Stock — Neutral
LEA Zacks Investment Research — July 28, 2025Explore Lear's (LEA) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

IQVIA (IQV) Reliance on International Sales: What Investors Need to Know — Neutral
IQV Zacks Investment Research — July 28, 2025Explore IQVIA's (IQV) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

Genuine Parts (GPC) Reliance on International Sales: What Investors Need to Know — Neutral
GPC Zacks Investment Research — July 28, 2025Examine Genuine Parts' (GPC) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

Understanding RPM International (RPM) Reliance on International Revenue — Negative
RPM Zacks Investment Research — July 28, 2025Review RPM International's (RPM) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.

International Markets and Danaher (DHR): A Deep Dive for Investors — Neutral
DHR Zacks Investment Research — July 28, 2025Explore how Danaher's (DHR) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

Understanding Dover (DOV) Reliance on International Revenue — Neutral
DOV Zacks Investment Research — July 28, 2025Explore how Dover's (DOV) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

Don't Overlook Equifax (EFX) International Revenue Trends While Assessing the Stock — Neutral
EFX Zacks Investment Research — July 28, 2025Examine Equifax's (EFX) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

Tesla (TSLA) International Revenue Performance Explored — Neutral
TSLA Zacks Investment Research — July 28, 2025Explore how Tesla's (TSLA) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

Investing in Lamb Weston (LW)? Don't Miss Assessing Its International Revenue Trends — Neutral
LW Zacks Investment Research — July 28, 2025Explore Lamb Weston's (LW) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

Vale to Report Q2 Earnings: What's in Store for the Stock? — Neutral
VALE Zacks Investment Research — July 28, 2025VALE braces for declines in Q2 sales and earnings, with weak iron ore prices and lower volumes offsetting volume gains in copper and nickel.

Should You Buy, Sell, or Hold Unisys Stock Before Q2 Earnings? — Neutral
UIS Zacks Investment Research — July 28, 2025UIS' Q2 results may reflect growth in AI and digital workplace wins, tempered by L&S timing and margin pressures.

NEE or SO: Which Utility Stock Deserves a Spot in Your Portfolio? — Positive
NEE SO Zacks Investment Research — July 28, 2025NEE and SO are both betting big on renewables; see how they compare on earnings growth, dividends, and price performance.
